Anti-inflammatory Property of Galectin-1 in a Murine Model of Allergic Airway Inflammation

Galectin-1 (Gal-1) has immunomodulatory activities in various allergic inflammatory disorders, but its potential anti-inflammatory properties on allergic airway diseases have not been confirmed. We explored the pharmacological effects of Gal-1 on the progression of allergic airway inflammation and i...

Full description

Saved in:
Bibliographic Details
Main Authors: Yunxiang Lv, Mengyuan Dai, Muzi Wang, Fangfang Chen, Rongyu Liu
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2019/9705327
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551122564284416
author Yunxiang Lv
Mengyuan Dai
Muzi Wang
Fangfang Chen
Rongyu Liu
author_facet Yunxiang Lv
Mengyuan Dai
Muzi Wang
Fangfang Chen
Rongyu Liu
author_sort Yunxiang Lv
collection DOAJ
description Galectin-1 (Gal-1) has immunomodulatory activities in various allergic inflammatory disorders, but its potential anti-inflammatory properties on allergic airway diseases have not been confirmed. We explored the pharmacological effects of Gal-1 on the progression of allergic airway inflammation and investigated the underlying mechanism. Female C57BL/6 mice were sensitized on day 0 and challenged with ovalbumin (OVA) on days 14-17 to establish an allergic airway inflammation model. In the challenge phase, a subset of mice was treated intraperitoneally with recombinant Gal-1 (rGal-1) or dexamethasone (Dex). We found that rGal-1 inhibited pulmonary inflammatory cell recruitment, mucus secretion, bronchoalveolar lavage fluid (BALF) inflammatory cell infiltration, and cytokine production. The treatment also suppressed the infiltration of eosinophils into the allergic lung as indicated by decreased expression levels of eotaxin and eosinophil peroxidase (EPX). However, only the expression levels of IL-25, neither IL-33 nor TSLP, were significantly decreased in the lung by rGal-1 treatment. These immunomodulatory effects in the allergic lung were correlated with the activation of extracellular signal-regulated kinase (ERK) signaling pathway and downregulation of endogenous Gal-1. In addition, rGal-1 reduced the plasma concentrations of anti-OVA immunoglobulin E (IgE) and IL-17. Our findings suggest that rGal-1 is an effective therapy for allergic airway inflammation in a murine model and may be a potential pharmacological target for allergic airway inflammatory diseases.
format Article
id doaj-art-7e04c0e61acd40eaa21feef70c7b9693
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-7e04c0e61acd40eaa21feef70c7b96932025-02-03T06:04:56ZengWileyJournal of Immunology Research2314-88612314-71562019-01-01201910.1155/2019/97053279705327Anti-inflammatory Property of Galectin-1 in a Murine Model of Allergic Airway InflammationYunxiang Lv0Mengyuan Dai1Muzi Wang2Fangfang Chen3Rongyu Liu4Department of Pulmonary Medicine, Anhui Geriatric Institute, The First Affiliated Hospital of Anhui Medical University, Jixi Road 218, Hefei, Anhui 230022, ChinaDepartment of Pulmonary Medicine, Anhui Geriatric Institute, The First Affiliated Hospital of Anhui Medical University, Jixi Road 218, Hefei, Anhui 230022, ChinaDepartment of Pulmonary Medicine, Anhui Geriatric Institute, The First Affiliated Hospital of Anhui Medical University, Jixi Road 218, Hefei, Anhui 230022, ChinaDepartment of Pulmonary Medicine, Anhui Geriatric Institute, The First Affiliated Hospital of Anhui Medical University, Jixi Road 218, Hefei, Anhui 230022, ChinaDepartment of Pulmonary Medicine, Anhui Geriatric Institute, The First Affiliated Hospital of Anhui Medical University, Jixi Road 218, Hefei, Anhui 230022, ChinaGalectin-1 (Gal-1) has immunomodulatory activities in various allergic inflammatory disorders, but its potential anti-inflammatory properties on allergic airway diseases have not been confirmed. We explored the pharmacological effects of Gal-1 on the progression of allergic airway inflammation and investigated the underlying mechanism. Female C57BL/6 mice were sensitized on day 0 and challenged with ovalbumin (OVA) on days 14-17 to establish an allergic airway inflammation model. In the challenge phase, a subset of mice was treated intraperitoneally with recombinant Gal-1 (rGal-1) or dexamethasone (Dex). We found that rGal-1 inhibited pulmonary inflammatory cell recruitment, mucus secretion, bronchoalveolar lavage fluid (BALF) inflammatory cell infiltration, and cytokine production. The treatment also suppressed the infiltration of eosinophils into the allergic lung as indicated by decreased expression levels of eotaxin and eosinophil peroxidase (EPX). However, only the expression levels of IL-25, neither IL-33 nor TSLP, were significantly decreased in the lung by rGal-1 treatment. These immunomodulatory effects in the allergic lung were correlated with the activation of extracellular signal-regulated kinase (ERK) signaling pathway and downregulation of endogenous Gal-1. In addition, rGal-1 reduced the plasma concentrations of anti-OVA immunoglobulin E (IgE) and IL-17. Our findings suggest that rGal-1 is an effective therapy for allergic airway inflammation in a murine model and may be a potential pharmacological target for allergic airway inflammatory diseases.http://dx.doi.org/10.1155/2019/9705327
spellingShingle Yunxiang Lv
Mengyuan Dai
Muzi Wang
Fangfang Chen
Rongyu Liu
Anti-inflammatory Property of Galectin-1 in a Murine Model of Allergic Airway Inflammation
Journal of Immunology Research
title Anti-inflammatory Property of Galectin-1 in a Murine Model of Allergic Airway Inflammation
title_full Anti-inflammatory Property of Galectin-1 in a Murine Model of Allergic Airway Inflammation
title_fullStr Anti-inflammatory Property of Galectin-1 in a Murine Model of Allergic Airway Inflammation
title_full_unstemmed Anti-inflammatory Property of Galectin-1 in a Murine Model of Allergic Airway Inflammation
title_short Anti-inflammatory Property of Galectin-1 in a Murine Model of Allergic Airway Inflammation
title_sort anti inflammatory property of galectin 1 in a murine model of allergic airway inflammation
url http://dx.doi.org/10.1155/2019/9705327
work_keys_str_mv AT yunxianglv antiinflammatorypropertyofgalectin1inamurinemodelofallergicairwayinflammation
AT mengyuandai antiinflammatorypropertyofgalectin1inamurinemodelofallergicairwayinflammation
AT muziwang antiinflammatorypropertyofgalectin1inamurinemodelofallergicairwayinflammation
AT fangfangchen antiinflammatorypropertyofgalectin1inamurinemodelofallergicairwayinflammation
AT rongyuliu antiinflammatorypropertyofgalectin1inamurinemodelofallergicairwayinflammation